Last update 08 May 2025

ELB-245

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target-
Action-
Mechanism-
Therapeutic Areas
Urogenital Diseases
Active Indication-
Inactive Indication
Urinary Bladder, OveractiveUrinary Incontinence
Originator Organization
elbion AG
Active Organization-
Inactive Organization
elbion AG
License Organization-
Drug Highest PhaseDiscontinuedPhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with ELB-245
NCT00439192
/ TerminatedPhase 2
A Multicenter, Randomized, Double-Blind, Parallel Group, Phase II, Forced Dose Titration Study to Investigate the Efficacy and Safety of 400mg and 600mg ELB245 Given Once Daily for 12 Weeks (8 + 4 Weeks) Versus Placebo and Versus 4mg Tolterodine Given Once Daily in Patients With Incontinent Overactive Bladder (OAB)
100 Clinical Results associated with ELB-245
Login to view more data
100 Translational Medicine associated with ELB-245
Login to view more data
100 Patents (Medical) associated with ELB-245
Login to view more data
100 Deals associated with ELB-245
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Urinary Bladder, OveractivePhase 2
Sweden
elbion AG
01 Feb 2007
Urinary Bladder, OveractivePhase 2
Poland
elbion AG
01 Feb 2007
Urinary Bladder, OveractivePhase 2
Germany
elbion AG
01 Feb 2007
Urinary IncontinencePhase 2
Sweden
elbion AG
01 Feb 2007
Urinary IncontinencePhase 2
Poland
elbion AG
01 Feb 2007
Urinary IncontinencePhase 2
Germany
elbion AG
01 Feb 2007
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free